Syros Pharmaceuticals (SYRS) Insider Trading & Ownership $0.20 0.00 (-0.89%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.26%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$206,490.57Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$225,493.85 Get SYRS Insider Trade Alerts Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SYRS Insider Buying and Selling by Quarter Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Syros Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Nancy A SimonianDirectorSell37,070$0.27$10,008.90 11/25/2024Nancy A SimonianDirectorSell134,713$0.27$36,372.51 9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92 9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.00 9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.65 6/28/2024Richard A YoungDirectorSell34,837$5.12$178,365.44 4/2/2024David RothInsiderSell150$4.98$747.00 (Data available from 1/1/2013 forward) SYRS Insider Trading Activity - Frequently Asked Questions Who is on Syros Pharmaceuticals's Insider Roster? The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Nancy A Simonian, Richard A Young, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS. What percentage of Syros Pharmaceuticals stock is owned by insiders? 12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings. Which Syros Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), Jason Haas ($130,990.57), and Srinivas Akkaraju ($3,999,998.34). How much insider buying is happening at Syros Pharmaceuticals? Insiders have purchased a total of 1,035,684 SYRS shares in the last 24 months for a total of $4,206,488.91 bought. Which Syros Pharmaceuticals insiders have been selling company stock? The following insiders have sold SYRS shares in the last 24 months: David Roth ($54,605.25), Eric R Olson ($2,411.50), Nancy A Simonian ($46,381.41), and Richard A Young ($178,365.44). How much insider selling is happening at Syros Pharmaceuticals? Insiders have sold a total of 221,094 Syros Pharmaceuticals shares in the last 24 months for a total of $281,763.60 sold. Syros Pharmaceuticals Key ExecutivesMr. Conley Chee (Age 54)CEO, President & Director Compensation: $672.24k1 recent tradesDr. Richard A. Young Ph.D. (Age 70)Scientific Founder, Member of Scientific Advisory Board & Director Compensation: $51.75kMr. Jason Haas (Age 56)Chief Financial Officer Compensation: $672.22k2 recent tradesDr. David A. Roth M.D. (Age 61)Chief Medical Officer Compensation: $715.73kDr. James E. Bradner M.D. (Age 52)Founder Dr. Nathanael S. Gray Ph.D.Scientific Founder & Member of Scientific Advisory BoardMs. Karen Hunady M.S.Director of Corporate Communications & Investor RelationsMr. Gerald E. Quirk Esq. (Age 56)J.D., Chief Legal Officer & Head of Business Development Compensation: $127.07kMs. Lisa RobertsVice President of Human ResourcesMs. Kristin Stephens (Age 51)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies MiNK Therapeutics Insider Transactions Mannatech Insider Transactions Athira Pharma Insider Transactions GeoVax Labs Insider Transactions IN8bio Insider Transactions Cocrystal Pharma Insider Transactions Bullfrog AI Insider Transactions Cognition Therapeutics Insider Transactions Finch Therapeutics Group Insider Transactions Unity Biotechnology Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:SYRS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYRS Stock Alerts